Reprogramming Dedifferentiation Regulatory Networks Preserves Human Chondrocyte Phenotypes
Authors:
Preprint
Abstract
Chondrocyte-based cartilage repair strategies such as autologous chondrocyte implantation (ACI) require extensive in vitro expansion to obtain clinically relevant cell numbers. However, this expansion step progressively drives chondrocyte dedifferentiation, reducing matrix-forming capacity and contributing to variable repair outcomes. To better understand this process, we used single-nucleus multiome profiling (snRNA-Seq + snATAC-Seq) to define the transcriptional and chromatin accessibility programs underlying human chondrocyte dedifferentiation during expansion. Multiome integration across passages revealed a continuous dedifferentiation trajectory accompanied by coordinated remodeling of gene expression and chromatin accessibility, identifying chromatin destabilization as an early regulatory event during phenotype loss. Guided by these regulatory signatures, we screened available small-molecule inhibitors targeting candidate pathways and found that Fludarabine most consistently preserved chondrocyte identity during early expansion. Fludarabine was associated with suppression of STAT1-related programs and early stabilization of the chromatin landscape prior to broader transcriptional recovery. Functionally, treated cells demonstrated enhanced matrix-forming capacity in chondrogenic pellet culture and significantly increased nascent protein synthesis in 3D hydrogel culture, with biosynthetic output approaching unexpanded controls by day 21. Together, these findings identify chromatin stability as a key regulatory determinant of expansion-associated chondrocyte dedifferentiation and establish a pharmacologic strategy to preserve chondrocyte functional potency during cell manufacturing for cartilage repair.Keywords
Funding Information
- National Institutes of Health (AR079224)
- National Institutes of Health (AR080581)
- National Institutes of Health (HL163168)
- U.S. National Science Foundation (CMMI-1578571)
This publication has 58 references indexed in Scilit:
- Transient Exposure to Transforming Growth Factor Beta 3 Under Serum-Free Conditions Enhances the Biomechanical and Biochemical Maturation of Tissue-Engineered CartilageTissue Engineering Part A, 2008
- Multiplication of Human Chondrocytes with Low Seeding Densities Accelerates Cell Yield without Losing Redifferentiation CapacityTissue Engineering, 2004
- Redifferentiation of dedifferentiated human chondrocytes in high-density culturesCell and tissue research, 2002
- Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell cultureOsteoarthritis and Cartilage, 2002
- Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tensionOsteoarthritis and Cartilage, 2002
- Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factorRheumatology, 2001
- Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signalingNature Medicine, 1999
- Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?Osteoarthritis and Cartilage, 1999
- Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte TransplantationNew England Journal of Medicine, 1994
- Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gelsCell, 1982